Loading...

ACXP ACURX PHARMACEUTICALS INC Operational Disruptions 8-K Filing

CRX

CXP

ACURX PHARMACEUTICALS INC

(ACXP)

2023 8-K

Stock Offering Details

Salary Reductions Note

Special Meeting Results

Reverse Stock Split

Reverse Stock Split

Warrant Inducement

Financial Statements

Equity Offerings

Nasdaq Compliance

Securities Offering

Nasdaq Notification

Clinical Trial Update

Financial Statements, Earni...

Merger of Equals

Other Special Situation

Sales Agreement

Phase 2 Results Announcement

Quarterly Earnings Reports

Material Defaults

Securities Purchase Agreement

Quantitative Data

External Links:

Acurx Pharmaceuticals announced positive Phase 2 results for ibezapolstat with a 96% clinical cure rate in patients with c. difficile infection.

AI Assistant

ACURX PHARMACEUTICALS INC

2023

8 K

Find Answers

Ask about any part of the document to get insights, explanations, or key details.